Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HBx Enhances the Nrf2/ARE-dependent Antioxidant Response by Promoting Nuclear Export and Downregulation of Bach1. | Kobe J Med Sci | 2026 | 42805912 | PubTator, text mining | PubMed |
| Ferroptosis-driven cell death perpetuates the chronic inflammatory cycle in periodontitis: a single-cell transcriptomic study. | Front Cell Dev Biol | 2026 | 42780883 | PubTator, text mining | PubMed |
| Cell type-specific histone acetylation landscape in Alzheimer's disease reveals a putative role of MITF in microglia. | bioRxiv | 2026 | 42779635 | PubTator, text mining | PubMed |
| Heme as a versatile signaling molecule: Coordinating mitochondrial metabolism with global cellular responses. | J Biol Chem | 2026 | 42705539 | PubTator, text mining | PubMed |
| Structural and thermodynamic analysis of BRCA1 BRCT variants identified in Middle Eastern breast cancer cohorts. | Protein Pept Lett | 2026 | 42692369 | PubTator, text mining | PubMed |
| Endothelial EPAS1 as a prognostic and therapeutic target in acute myocardial infarction: integrative bioinformatics, Mendelian randomization and experimental validation. | Front Pharmacol | 2026 | 42614148 | PubTator, text mining | PubMed |
| BACH1/HO-1 axis dysregulation links Down syndrome to Alzheimer-like neurodegeneration. | Neurochem Int | 2026 | 42532345 | PubTator, text mining | PubMed |
| Elevated BACH1 Contributes to Mitochondrial Succinylome Remodeling and Trophoblast Bioenergetic Dysfunction in Preeclampsia. | Antioxidants (Basel) | 2026 | 42510566 | PubTator, text mining | PubMed |
| Targeting the hsa-miR-155-5p-BACH1-MMP-9 Signaling Hub in Lung Cancer: A Novel Anticancer Mechanism of Thymoquinone. | Biomolecules | 2026 | 42509749 | PubTator, text mining | PubMed |
| Clinical Relevance of BACH1 Expression in Non-Small Cell Lung Cancer. | Int J Cancer | 2026 | 42503861 | PubTator, text mining | PubMed |
| Heme oxygenase-1/CO signaling suppresses NLRP3 inflammasome-mediated stromal fibrosis in primary myelofibrosis. | Free Radic Biol Med | 2026 | 42476324 | PubTator, text mining | PubMed |
| The transcription factor BACH1 couples chromatin priming and repression to enable macrophage plasticity and adaptation. | Immunity | 2026 | 42468527 | PubTator, text mining | PubMed |
| BACH1 meets its match: Heme licenses BACH1 destruction to tune ferroptosis. | Cell Chem Biol | 2026 | 42462695 | PubTator, text mining | PubMed |
| Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis. | Front Immunol | 2026 | 42459705 | PubTator, text mining | PubMed |
| Regulating the BACH1/NCOA4 axis to disrupt UPEC-induced intracellular bacterial communities: Tailin patent formula alleviates bladder epithelial injury by inhibiting ferritinophagy and ferroptosis. | Phytomedicine | 2026 | 42447508 | PubTator, text mining | PubMed |
| Reduction of monocyte activation and oxidative stress by phosphodiesterase 4 blockade in Behçet's syndrome. | Clin Rheumatol | 2026 | 42432372 | PubTator, text mining | PubMed |
| Metformin-restricted motility of an NRF2-activated lung cancer cell line involves NAD+ depletion, rather than AMPK- or BACH1 signaling. | Sci Rep | 2026 | 42414524 | PubTator, text mining | PubMed |
| Beyond KEAP1: The Context-Specific NRF2 Partner Code in Disease and Therapy. | Antioxidants (Basel) | 2026 | 42352065 | PubTator, text mining | PubMed |
| BACH1 inhibition confers neuroprotection after subarachnoid hemorrhage through activation of the Nrf2 signaling pathway. | Brain Res Bull | 2026 | 42341848 | PubTator, text mining | PubMed |
| Beyond Raf-1 inhibition: RKIP's multifaceted roles in cellular homeostasis. | Biochim Biophys Acta Rev Cancer | 2026 | 42323054 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers